To generate and characterize mouse models of Vma21 deficiency to study the pathogenesis of X-linked myopathy with excessive autophagy (XMEA), a rare neuromuscular disorder.
Approach:
Model Generation: Conditional knockout mice for Vma21 were created using the CRISPR-Cas9 system to study the effects of Vma21 deficiency.
Experimental Protocols: Mice were housed under controlled conditions, and various genotyping and histological analyses were performed to assess the impact of Vma21 deletion.
Key Findings:
Skeletal muscle-specific Vma21 deletion recapitulates hallmark features of XMEA, including progressive myopathy and autophagic dysregulation.
Combined skeletal and cardiac muscle deletion leads to early lethal cardiomyopathy with autophagic impairment.
Histopathological analysis shows cytoplasmic vacuoles and other pathological features characteristic of XMEA.
Interpretation:
The generated mouse models provide a relevant system for studying the pathogenesis of XMEA.
Limitations:
The study does not fully elucidate the mechanisms by which Vma21 deficiency leads to muscle pathology.
The models may not completely replicate all aspects of human XMEA.
Conclusion:
The study establishes a physiologically relevant in vivo system for further investigation into XMEA.
by Christian A. Suarez, Sara K. Pittman, Michio Inoue, Eileen M. Lynch, Andrew Moran, Angèle N. Merlet, Emmanuelle Lacenne, Teresinha Evangelista, Conrad C. Weihl
Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.
